Atrys Spain
Cancer clinic in Barcelona, Spain

Add to Comparison

About Atrys Spain

Atrys is a global company dedicated to providing precision diagnostic services and state-of-the-art treatment for diseases such as cancer. Their network of five specialised radiotherapy oncology centres in Spain, Switzerland and Portugal offers cancer patients access to the highest quality, personalised care from a team of experts using the very latest treatments and technologies.

Atrys Oncology Network

The leading cancer centres of the network based in Barcelona work through a healthcare model whereby pathologists and oncologists share protocols and jointly discuss each case in weekly international tumour committees. Atrys offers patients any type of treatment they may need in the course of their illness, with personalised solutions for each case. Patients are accompanied throughout the path of the disease from its precise diagnosis to surgery and chemotherapy, radiotherapy, or immunotherapy treatments.

Atrys provides patients with the highest quality diagnoses and treatments and standardised care across their network.

Atrys comprises a team of experts with international experience, supported by the most advanced technology. Offering state-of-the-art, personalised cancer care, each case is overseen by the multidisciplinary tumour committee. The committee shares the latest medical-scientific advances, best clinical practices, medical advice and comes to an agreement so that the patient always receives the best therapeutic option. Cancer care at Atrys centres is comprehensive.

Their specialised units are at the service of their patients:

  • Precision Oncology Diagnostic Unit
  • High Precision Radiotherapy Unit
  • Medical Oncology Unit

State-of-the-art radiotherapy

Atrys oncologists were pioneers in the use and establishment of hypofractionated radiotherapy techniques in Europe. Their physicians have a broad experience in the use of state-of-the-art treatments. Atrys’s oncology centres are equipped with the most advanced radiotherapy treatments such as Image Guided Single Dose Radiation Therapy (SD-IGRT) and hypofractionated radiotherapy.

SD-IGRT allows high doses of radiation to be delivered very precisely, greatly reducing the impact on healthy tissues. The treatment can be delivered in a single session and subject to specialist consultation can be used to remove a tumour at an early stage, providing new therapy options for patients who are unable to undergo surgery or who do not have other effective treatments available to them.

Extreme Hypofractionated radiotherapy is an advanced technique that is increasingly being used to treat a range of cancers. During hypofractionation, more intensity of radiation is delivered per session, so a lower number of sessions (2-5) are needed allowing patients to complete their course of radiation therapy more quickly with the possibility of fewer short term side effects and a better quality of life.

External radiotherapy

External radiotherapy utilises high-energy rays produced by a linear accelerator, which are directed from outside of the body precisely towards a tumour. It is generally used either to eliminate cancer or in cases that require prevention of a recurrence. It can also be used as a palliative treatment to alleviate difficult symptoms caused by the presence of metastasis or advanced cancer.

External radiotherapy treatments available at Atrys are:

  • Conventional External Radiotherapy
    - 3D Radiotherapy
    - IMRT (Intensity Modulated Radiation Therapy)
  • Advanced External Radiotherapy
    - Frameless fractionated stereotactic radiosurgery
    - IGRT (Image-guided radiotherapy)
    - VMAT (Volumetric Modulated Arc Therapy)
    - SBRT. Extracranial radiosurgery
    - 4D Radiotherapy


Brachytherapy is a type of radiation therapy in which a small radioactive material called a source is placed inside the body, inside or close to the cancer. It is commonly used for prostate cancer, both as a low dose monotherapy in cases where the tumour is limited to the prostate and as a high dose in combination with radiotherapy and/or hormone therapy treatment.

The radiation dose in prostate brachytherapy is confined to the gland and does not affect neighbouring organs. The technique has several advantages: it avoids invasive surgery, is placed only once, allows a rapid recovery, avoids urinary incontinence and allows sexual drive to be maintained in more than 90% of cases.

Brachytherapy is also used in cases of breast cancer, gynaecological cancers and eye cancers.

Brachytherapy treatments available are:

  • HDR Gynaecological cancers
  • HDR Prostate Cancer
  • HDR Brachytherapy with Ir-192 source
  • Prostate brachytherapy with I-125 seeds
  • Ophthalmic brachytherapy with RU-106 applicators or with I-125 seeds

Second opinion and genetic counselling

Atrys provides second opinion oncology consultations for people diagnosed with cancer who want to get a second opinion from an expert team and discuss treatment options. They also provide genetic counselling for people who are suffering from cancer or who have a family history of the condition.


Atrys-IMOR (Medical Institute of Oncological Radiotherapy) in Barcelona is a pioneering cancer centre specialising in brachytherapy and radiotherapy. Equipped with the latest technologies, the Institute offers treatment for a wide range of cancers at any stage, including prostate cancer, lung cancer, uterine cancer, bladder cancer, gastric cancer, breast cancer, brain tumours and bone cancer.

The treatments available at Atrys-IMOR are designed to provide the best results for patients, both in terms of efficacy in the fight against cancer and in the health and well-being of the patient during the treatment process and beyond. Using the most advanced techniques and systems, potential side effects are reduced and in many cases the duration of treatment is considerable shortened.

Atrys-IMOR has been awarded the highly prestigious Judith Sitt Prize by American Brachytherapy Society for its outstanding contribution to the conservative treatment of prostate cancer and to the continuous improvement of the quality of life of patients with prostate cancer.

The Institute has also obtained the Joint Commission International certificate for ambulatory care, considered the highest quality seal in the world in the health field in this category.


Atrys has combined with Sanitas, Spain’s largest medical insurance company, to provide specialist diagnostics and cancer treatment at the new Institute of Advanced Oncology (IOA) at Hospital CIMA in Barcelona. The Institute is part of Bupa and open to private patients and other insurances.

Atrys-IOA comprises a team of experts with international experience, supported by the most advanced technology. Offering state-of-the-art, personalised cancer care, their medical professionals work hand in hand with the oncology nursing unit.

Each case is overseen by the multidisciplinary tumour committee, bringing together oncology specialists, the nursing team, radiologists, surgeons, and genetic counsellors. The committee shares the latest medical-scientific advances, best clinical practices, medical advice and comes to an agreement so that the patient always receives the best therapeutic option.

Cancer care at IOA is comprehensive, calling on the support of psycho-oncologists, nutritionists, endocrinologists, physiotherapists and aesthetic experts.

Personalised, state-of-the-art cancer care in Spain

Each person is different, each cancer is different. Atrys’ top cancer centres in Barcelona work to treat each case in a personalised and precise way. An individualised response for a path on which you are not alone.

To find out how Atrys Spain can help, get in touch with Atrys Oncology at

[email protected]

Languages spoken

  • English
  • French
  • Spanish
  • Russian

Opening hours

Mon: 09:00 – 22:00
Tues: 09:00 – 22:00
Wed: 09:00 – 22:00
Thurs: 09:00 – 22:00
Fri: 09:00 – 22:00


Liability insurance  : No


Contact details

Main Phone: 
Email: [email protected]